These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 17403700)

  • 1. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model.
    LaPlante KL; Mermel LA
    Nephrol Dial Transplant; 2007 Aug; 22(8):2239-46. PubMed ID: 17403700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections.
    Bookstaver PB; Williamson JC; Tucker BK; Raad II; Sherertz RJ
    Ann Pharmacother; 2009 Feb; 43(2):210-9. PubMed ID: 19193593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dynamic in vitro model for evaluating antimicrobial activity against bacterial biofilms using a new device and clinical-used catheters.
    García I; Conejo Mdel C; Ojeda A; Rodríguez-Baño J; Pascual A
    J Microbiol Methods; 2010 Dec; 83(3):307-11. PubMed ID: 20888868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of telavancin and vancomycin lock solutions in eradication of biofilm-producing staphylococci and enterococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2016 Mar; 73(5):315-21. PubMed ID: 26896504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
    Wiederhold NP; Coyle EA; Raad II; Prince RA; Lewis RE
    J Antimicrob Chemother; 2005 May; 55(5):792-5. PubMed ID: 15814598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection.
    Meije Y; Almirante B; Del Pozo JL; Martín MT; Fernández-Hidalgo N; Shan A; Basas J; Pahissa A; Gavaldà J
    J Infect; 2014 Jun; 68(6):548-52. PubMed ID: 24412247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
    J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
    Lee JY; Ko KS; Peck KR; Oh WS; Song JH
    J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm.
    Aybar Y; Ozaras R; Besirli K; Engin E; Karabulut E; Salihoglu T; Mete B; Tabak F; Mert A; Tahan G; Yilmaz MH; Ozturk R
    Int J Antimicrob Agents; 2012 Apr; 39(4):338-42. PubMed ID: 22364717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution.
    Balestrino D; Souweine B; Charbonnel N; Lautrette A; Aumeran C; Traoré O; Forestier C
    Nephrol Dial Transplant; 2009 Oct; 24(10):3204-9. PubMed ID: 19383833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection.
    Fernández-Hidalgo N; Gavaldà J; Almirante B; Martín MT; Onrubia PL; Gomis X; Pahissa A
    J Antimicrob Chemother; 2010 Mar; 65(3):525-30. PubMed ID: 20083550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections.
    Van Praagh AD; Li T; Zhang S; Arya A; Chen L; Zhang XX; Bertolami S; Mortin LI
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4081-9. PubMed ID: 21709082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin.
    Brinch KS; Tulkens PM; Van Bambeke F; Frimodt-Møller N; Høiby N; Kristensen HH
    J Antimicrob Chemother; 2010 Aug; 65(8):1720-4. PubMed ID: 20534628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.
    Hajdu S; Lassnigg A; Graninger W; Hirschl AM; Presterl E
    J Orthop Res; 2009 Oct; 27(10):1361-5. PubMed ID: 19396814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Leonard SN; Rybak MJ
    J Antimicrob Chemother; 2009 Jan; 63(1):155-60. PubMed ID: 18984644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
    Raad I; Hanna H; Jiang Y; Dvorak T; Reitzel R; Chaiban G; Sherertz R; Hachem R
    Antimicrob Agents Chemother; 2007 May; 51(5):1656-60. PubMed ID: 17353249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.